Amalgamated Bank’s Abbott Laboratories Position
Does Amalgamated Bank own Abbott Laboratories (ABT)? Yes — 321.4K shares worth $33M (+0.25% of its 13F portfolio) as of Q1 2026, up from 321.1K shares the prior filed quarter.
Position Value
$33M
Q1 2026
Shares
321.4K
% of Portfolio
+0.25%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 321.4K | $33M | +0.25% |
| Q4 2025 | 321.1K | $40M | +0.29% |
| Q3 2025 | 355.8K | $48M | +0.34% |
| Q2 2025 | 362.1K | $49M | +0.38% |
| Q1 2025 | 340.7K | $45M | +0.39% |
| Q4 2024 | 336.8K | $38M | +0.31% |
| Q3 2024 | 343.6K | $39M | +0.32% |
| Q2 2024 | 350.8K | $36M | +0.31% |
| Q1 2024 | 360.4K | $41M | +0.35% |
| Q4 2023 | 419.2K | $46M | +0.37% |
| Q3 2023 | 439.8K | $43M | +0.36% |
| Q2 2023 | 453.9K | $49M | +0.40% |
| Q1 2023 | 462.6K | $47M | +0.40% |
| Q4 2022 | 455.3K | $50M | +0.45% |
| Q3 2022 | 477.5K | $46M | +0.45% |
| Q2 2022 | 443.3K | $48M | +0.45% |
| Q1 2022 | 483.7K | $57M | +0.44% |
| Q4 2021 | 489.1K | $69M | +0.51% |
| Q3 2021 | 434.9K | $51M | +0.43% |
| Q2 2021 | 452.0K | $52M | +0.42% |
| Q1 2021 | 99.6K | $12M | +0.45% |
| Q4 2020 | 103.7K | $11M | +0.43% |
| Q3 2020 | 104.0K | $11M | +0.49% |
| Q2 2020 | 106.6K | $10M | +0.45% |
| Q1 2020 | 267.8K | $21M | +0.52% |
| Q4 2019 | 277.0K | $24M | +0.44% |
| Q3 2019 | 262.4K | $22M | +0.46% |
| Q2 2019 | 240.0K | $20M | +0.47% |
| Q1 2019 | 219.1K | $18M | +0.42% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amalgamated Bank’s full portfolio or all institutional holders of ABT.